780 related articles for article (PubMed ID: 28165675)
21. Review shows that using surfactant a number of times or as a vehicle for budesonide may reduce the risk of bronchopulmonary dysplasia.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Daoud P; Zupan V; Moreau F; Guilhoto I; Rouabah M; Alexandre C; Saliba E; Storme L; Patkai J; Pomedio M; Hamon I
Acta Paediatr; 2018 Jul; 107(7):1140-1144. PubMed ID: 29193276
[TBL] [Abstract][Full Text] [Related]
22. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study.
Yeh TF; Lin HC; Chang CH; Wu TS; Su BH; Li TC; Pyati S; Tsai CH
Pediatrics; 2008 May; 121(5):e1310-8. PubMed ID: 18426851
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy of different preparations of budesonide combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome: a comparative analysis].
Ke H; Li ZK; Yu XP; Guo JZ
Zhongguo Dang Dai Er Ke Za Zhi; 2016 May; 18(5):400-4. PubMed ID: 27165587
[TBL] [Abstract][Full Text] [Related]
24. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
[TBL] [Abstract][Full Text] [Related]
25. Animal derived surfactant extract for treatment of respiratory distress syndrome.
Seger N; Soll R
Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
[TBL] [Abstract][Full Text] [Related]
26. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2012 Apr; (4):CD002311. PubMed ID: 22513906
[TBL] [Abstract][Full Text] [Related]
27. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.
Aldana-Aguirre JC; Pinto M; Featherstone RM; Kumar M
Arch Dis Child Fetal Neonatal Ed; 2017 Jan; 102(1):F17-F23. PubMed ID: 27852668
[TBL] [Abstract][Full Text] [Related]
28. Surfactant and budesonide for respiratory distress syndrome: an observational study.
Kothe TB; Sadiq FH; Burleyson N; Williams HL; Anderson C; Hillman NH
Pediatr Res; 2020 Apr; 87(5):940-945. PubMed ID: 31715622
[TBL] [Abstract][Full Text] [Related]
29. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
30. Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.
Bassler D; Plavka R; Shinwell ES; Hallman M; Jarreau PH; Carnielli V; Van den Anker JN; Meisner C; Engel C; Schwab M; Halliday HL; Poets CF;
N Engl J Med; 2015 Oct; 373(16):1497-506. PubMed ID: 26465983
[TBL] [Abstract][Full Text] [Related]
31. Use of budesonide associated with a pulmonary surfactant to prevent bronchopulmonary dysplasia in premature newborns - A systematic review.
Moraes LHA; Coelho RMD; Neves Dos Santos Beozzo GP; Yoshida RAM; de Albuquerque Diniz EM; de Carvalho WB
J Pediatr (Rio J); 2023; 99(2):105-111. PubMed ID: 36436670
[TBL] [Abstract][Full Text] [Related]
32. Inhaled budesonide for the prevention of bronchopulmonary dysplasia.
Bassler D
J Matern Fetal Neonatal Med; 2017 Oct; 30(19):2372-2374. PubMed ID: 27756156
[TBL] [Abstract][Full Text] [Related]
33. Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome.
Wang XA; Chen LJ; Chen SM; Su PH; Chen JY
Pediatr Neonatol; 2020 Apr; 61(2):210-215. PubMed ID: 31818537
[TBL] [Abstract][Full Text] [Related]
34. Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part II. Inhaled corticosteroids alone or in combination with surfactants.
Szabó H; Baraldi E; Colin AA
Pediatr Pulmonol; 2022 Apr; 57(4):787-795. PubMed ID: 34964564
[TBL] [Abstract][Full Text] [Related]
35. Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence.
Poets CF; Lorenz L
Arch Dis Child Fetal Neonatal Ed; 2018 May; 103(3):F285-F291. PubMed ID: 29363502
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive approach to the prevention of bronchopulmonary dysplasia.
Kugelman A; Durand M
Pediatr Pulmonol; 2011 Dec; 46(12):1153-65. PubMed ID: 21815280
[TBL] [Abstract][Full Text] [Related]
37. Bubble nasal CPAP, early surfactant treatment, and rapid extubation are associated with decreased incidence of bronchopulmonary dysplasia in very-low-birth-weight newborns: efficacy and safety considerations.
Friedman CA; Menchaca RC; Baker MC; Rivas CK; Laberge RN; Rios EH; Haider SH; Romero EJ; Eason EB; Fraley JK; Woldesenbet M
Respir Care; 2013 Jul; 58(7):1134-42. PubMed ID: 23106970
[TBL] [Abstract][Full Text] [Related]
38. Surfactant administration via a thin endotracheal catheter during spontaneous breathing in preterm infants.
Wu W; Shi Y; Li F; Wen Z; Liu H
Pediatr Pulmonol; 2017 Jun; 52(6):844-854. PubMed ID: 28152280
[TBL] [Abstract][Full Text] [Related]
39. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
[No Abstract] [Full Text] [Related]
40. Minimally invasive surfactant administration in preterm infants: a meta-narrative review.
More K; Sakhuja P; Shah PS
JAMA Pediatr; 2014 Oct; 168(10):901-8. PubMed ID: 25089718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
